Archive | Longevity RSS feed for this section

A Perfect Match: CEO Successfully Navigates Early-Stage Investment

22 Apr

By Rory McCann, Marketing Manager & Conference Producer, LSN

APIE Therapeutics is an early-stage company developing vascular endothelium niche repair and regeneration. We spoke with CEO, Dr. Esther Alegría about the early days of APIE Therapeutics and the importance of fit when seeking capital and building a powerful team.

APIE Therapeutics is an Innovator’s Pitch Challenge winner at last month’s Longevity, Health & Innovation, a Redefining Early Stage Investments (RESI) partnering event. Learn more about RESI and sign up by May 7 to save $50 on early bird rates.

RESI Longevity, September 16-17, is now accepting Innovator’s Pitch Challenge applications. Learn more and sign up by July 23 to save!

Introducing RESI AI and RESI Longevity

22 Apr

By Caitlin Dolegowski, Marketing Specialist, LSN


Life Science Nation (LSN) renames its two newest conferences under the Redefining Early Stage Investments (RESI) banner. This conference series has provided early-stage life science entrepreneurs a space dedicated to their fundraising efforts through connecting them with partners and capital that are a fit for their product and stage of development. Through the years, LSN has worked with thousands of executives in their search for partnerships, and the secret has always been that it all comes down to finding that right fit. In order to help target these elusive matches, LSN spun two sister conferences, 4D Meets AI and Longevity, Health and Innovation, now RESI AI and RESI Longevity respectively, out of the RESI conference series, designed to further narrow down the early-stage life science players, based on technology and indication.

4D Meets AI has focused on connecting entrepreneurs using AI technology to advance drugs, devices, diagnostics, and digital health (4Ds) with investors and partners actively seeking AI applications in their themes and portfolios. Longevity, Health & Innovation, co-organized with Mary Furlong & Associates, is a space for fundraising executives targeting diseases that disproportionately affect aging populations to connect with capital and resources specifically in age-tech.

These two conferences are designed to create a more intimate atmosphere within the RESI partnering ecosystem. Each invites a unique attendee, yet both are a digital partnering conferences advancing the mission of the RESI series – to connect technology in life science and health care with well-fitting capital and channel partners – which is why they return this fall as RESI AI and RESI Longevity.

RESI Longevity and RESI AI both take place September 16-17 as two-day digital partnering conferences. Each will feature their own unique lineups of Investor Panels, Educational Workshops, Innovator’s Pitch Challenges and Premier Partnering Platforms. Learn more about each conference and sign up by July 23 to save $100 on super early bird prices!

Congratulations to the LHI Innovator’s Pitch Challenge Winners!

25 Mar

By Jessica Yang, Senior Research Analyst, Asia Business Development, LSN

Life Science Nation (LSN)’s 2-day Longevity, Health & Innovation (LHI) digital partnering conference took place March 18-19. We are very excited to announce the Top Winners of each Innovator’s Pitch Challenge (IPC) session. As the popularity grows for LHI IPC, we had three sessions featuring Therapeutics, Medical Devices & Diagnostics, and Digital Health companies. Attendees voted for their favorite companies based on materials available on the companies’ dedicated webpages, as well as their live pitch and Q&A.

Thank you to each IPC company for participating and sharing your technology and story with the LHI community. Congratulations to the winners, and thanks to all for voting!

Session 1 (Therapeutics) Tied Winners

APIE-Therapeutics, Inc is a preclinical stage biopharmaceutical company pioneering the endothelium vascular niche repair and regeneration platform. By harnessing activation of the Apelin-APJ receptor, we intend to improve patients’ lives suffering from chronic diseases such as Idiopathic Pulmonary Fibrosis (IPF), KidneyMembranous Glomerulonephritis (MGN) & Chronic Kidney Disease (CKD), Scleroderma (SSc) and others.

Panaceutics Rx uses its patented technologies to enable easy access to affordable personalized medicine and wellness, offering unique combination forms to improve adherence, delivered direct to patients. Our mission is to enable personalized combination products for prevention and chronic therapy, with aids to formulation based on an individual’s digital health profile. Individualized, optimized combinations are enabled to be made on-demand using our robotic platforms and patented processes. Under 503A regulatory rules, Panaceutics automates the compounding of individualized therapies to match physician’s prescriptions. We deliver individualized combination therapies in consumer-friendly forms that promote adherence.

Session 2 (Digital Health) Winner

LifeBio is an age-tech company that captures individuals’ life stories and increases social connectedness— to enhance mental health and to improve Alzheimer’s care.

Session 3 (Medical Devices & Diagnostics) Winner

Eye movements offer a window into brain health. neuroFit licensed a NASA-developed oculometric technology co-invented by one of our founders that delivers eye-movement-based metrics, some well-known from physiology (e.g., latency, acceleration, gain) and other more modern sensorimotor metrics (e.g., direction noise, speed tuning) distilled into a summary metric, nFit. Compared to biomarkers from imaging and EEG, oculometric approaches require only a visual display and a well-designed tracking system to yield noninvasive, low-cost biomarkers that can be scaled on consumer devices.

If you’re interested in the next upcoming Innovator’s Pitch Challenge, you can apply for the Digital RESI IPC taking place June 8-10. Applications close May 14!

This image has an empty alt attribute; its file name is digital-june-2021-banner-1100.png

Keep the Conversations Going

18 Mar

By Rory McCann, Marketing Manager & Conference Producer, LSN

Healthtech Partnering Week is off to the races! Digital RESI March has wrapped up with 1,000+ meetings in 3 days and leads into a triple-threat partnering experience consisting of 4D Meets AI, Access China Spring Forum (free), and Longevity, Health & Innovation taking place consecutively March 18-19.

It’s not too late to sign up and get involved in any of these three events! To learn more, visit the Healthtech Partnering Week website. Each conference offers unique opportunities suited for specific technology assets and market solutions. We hope you’ll join us and round out your RESI partnering with the full Healthtech Partnering Week experience!

Introducing Healthtech Partnering Week Innovator’s Pitch Challenge Finalists

11 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireLife Science Nation (LSN) is pleased to announce next week’s Healthtech Partnering Week (HPW) Innovator’s Pitch Challenge finalists. The Innovator’s Pitch Challenge is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session.

Pitching opportunities at LSN partnering events are popular events for startups and investors alike. They provide exposure and experience to the companies, while providing investors with insight into the latest technology organized by sector and interest. Check out our finalists and select a logo to learn more about their participation. Registration is still open, so don’t miss out and sign up today!

Innovator’s Pitch Challenge Finalists


Announcing McDermott Will & Emery HPW Workshops

11 Mar

By Gregory Mannix, Vice President International Business Development, LSN

Life Science Nation (LSN) is thrilled to welcome McDermott Will & Emery as Title Sponsor of Healthtech Partnering Week (HPW) with two live workshops accessible to registered attendees of Redefining Early Stage Investments (RESI) and 4D Meets AI.

McDermott Will & Emery has brought valuable insights to LSN’s community of early-stage fundraising companies, investors, service providers, and strategic partnerships for years, and we look forward to bringing their content to the digital stage next week. There’s still time to register for HPW – Sign up for access to McDermott Will & Emery workshops and more!

Negotiating Term Sheets: What’s Best for the Company and What’s Best for You?
Live Workshop! March 16 | 1 PM EDT (Register for RESI Access)


  • Nancy Briefs, President & CEO, AltrixBio, Inc.
  • David Hendren, Managing Director, Augmentum Ventures
  • Mark Mihanovic, Partner, McDermott Will & Emery
  • Aroma Sharma, Partner, McDermott Will & Emery

This interactive workshop, organized and led by McDermott Will & Emery, will provide wisdom to early-stage CEOs and management on the latest trends in term sheets, with a focus on founder and management equity opportunities. The workshop will cover common issues of concern to entrepreneurs (valuation/dilution, liquidation preference, board makeup, protective provisions, anti-dilution). Experts from the legal, investment and entrepreneurial community will discuss the interplay of financing milestones in the term sheet discussion. Learn more!

How to Go to Market: Commercializing AI-Based Health Technologies
Live Workshop! March 19 | 10 AM EDT (Register for 4D Meets AI Access)


  • Richie Bavasso, MBA, Co-Founder & CEO, nQ Medical Inc.
  • Carolyn Metnick, JD, Partner, McDermott Will & Emery
  • Michael Ryan, JD, Partner, McDermott Will & Emery
  • Dale Van Demark, JD, Partner, McDermott Will & Emery

This workshop, hosted by our Title Sponsor McDermott Will & Emery, will focus on the various options for and the legal considerations involved with commercializing AI-based healthcare technologies, including regulatory and data strategies. Learn about the range of options, from R&D use to consumer products, from leading members of McDermott’s digital health practice and companies that have blazed the trail. Learn more!

Got a Moment for a Great Match?

4 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireHealthtech Partnering Week (HPW) launches in just over a week, and the team at Life Science Nation (LSN) is proud to welcome 400+ investors to our digital platform to source portfolio assets across life science and healthcare. LSN works with exceptional early-stage companies to connect them with investors and strategic partners that are a fit for their product and stage of development, and one of the most powerful ways that is done is through digital partnering events where attendees can filter through hundreds of opportunities and find the best fits for their needs.

Check out our current list of confirmed investors and sign up to begin booking meetings and making deals!

Confirmed Digital RESI March Investors and Strategic Partners

Confirmed RESI Investors Confirmed 4D Meets AI Investors Confirmed LHI Investors

%d bloggers like this: